MADRID, Feb. 20, 2018 /PRNewswire/ —
Dr Anna Farago, oncologist from the Massachusetts General Hospital and principal investigator of the phase III ATLANTIS clinical trial, will present the potential of lurbinectedin in small-cell lung cancer along with the main clinical data…
